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accident or peripheral vascular disease. Diabetic 
atherosclerosis can be detected by measurement of 
intima-media thickness (IMT) of common or internal 
carotid artery (CIMT). The CIMT was used to predict 
of cardiovascular outcomes in diabetic patients.[8] 
The easy applicability and the noninvasive nature of 
B-mode ultrasonography make it suitable for using as 
a surrogate endpoint for measuring the atherosclerotic 
burden in people with cardiovascular risk factors.[9] 
The mean CIMT values by the different incidences 
were reported as 1.26 ± 0.6 mm (transversal), 1.17 ± 
0.54 mm (longitudinal anterolateral), and 1.18 ± 0.58 
mm (longitudinal posterolateral).[10] Increases in the 
thickness of the carotid IMT may be associated with 
an increased risk of myocardial infarction and stroke 
in old patients without a history of cardiovascular 
disease.[11] Mean CIMT was reported a reliable marker 
of risk of ischemic stroke in type 2 diabetic patients 
and could be used as a simple noninvasive screening 
test for the assessment of atherosclerosis in these 
patients.[12] Mean CIMT may be associated with age, 
systolic blood pressure (SBP), smoking, the ratio of 
low-density lipoprotein to high-density lipoprotein 
cholesterol, mean glycosylated hemoglobin value 
(HbA1c), and urinary albumin excretion rate.[13] In 
type 2 diabetic patients, significant predictors of 
IMT progression included albuminuria, advanced 
INTRODUCTION
Diabetes mellitus is the most common cause of 
end-stage renal disease, non-traumatic lower-limb 
amputation and blindness. Furthermore, diabetic 
retinopathy (DR) is the most important cause of visual 
loss worldwide. The prevalence of DR increases with 
duration of diabetes. Some other risk factors of DR 
development include poor glycemic control, type of 
diabetes, and the presence of associated disorders such 
as dyslipidemia, hypertension, smoking, pregnancy, 
and nephropathy.[1,2] DR could present as non-
proliferative retinopathy, proliferative retinopathy or 
macular edema, however, the most important cause of 
visual loss among these patients is macular edema.[3,4] 
Retinopathy is essential for the diagnosis of diabetic 
nephropathy, but it presents in 90% and 60% of type 
1 and 2 diabetic patients, respectively.[5] Because the 
rate of progression of retinopathy may be rapid, and 
treatment can be beneficial for reduction of disease 
progression, it is important to screen diabetic patients 
regularly for the development of retinopathy, so in 
type 1 diabetes, after 5 years and in type 2 diabetes, at 
the time of diagnosis and then annually, retinopathy 
should be evaluated.[6,7] One of the other complications 
of diabetes is generalized atherosclerosis which can be 
presented as ischemic heart disease, cerebrovascular 
Background: This study was carried out in order to evaluate the relationship between retinopathy and carotid intima-media 
thickness (CIMT). Materials and Methods: In a cross-sectional study, 154 diabetic patients who had a history of diabetic disease 
were evaluated in two equal groups of 77 patients with and without retinopathy, respectively. CIMT was evaluated in all of the 
patients. Results: Mean age of the patients was 59.65 ± 9.37 years. Mean CIMT of all patients was 0.84 ± 0.18. CIMT of patients 
with retinopathy was significantly greater than patients without retinopathy (P < 0.001). CIMT also correlated with age, duration of 
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age, male sex, smoking, and higher SBP.[14] In diabetic 
patients without a history of clinical CVD, the presence 
of advanced stage of DR is associated with subclinical 
coronary artery disease.[15,16] DR was shown as subclinical 
atherosclerosis marker, so retinopathy may warrant a 
more careful cardiovascular assessment even in the early 
stages of diabetes.[17]
Intima-media thickness is a sensitive marker of early carotid 
atherosclerosis, so ultrasound CIMT measurement can be 
used to assess the cardiovascular risk and to determine 
indications for intensified diabetic treatment; on the other 
hand, DR is an early and reliable marker of microvascular 
disease, and probably diabetic nephropathy,[18] so the 
aim of our study was evaluation of relationship between 
retinopathy and CIMT as two valuable noninvasive methods 
for early detection of micro and macrovascular complication 
of diabetes.
MATERIALS AND METHODS
In a cross-sectional study (2012), 154 diabetic patients who had a 
medical history and follow-up in Imam Ali Clinic of Shahrekord 
were enrolled in the study. They were divided into two equal 
groups of 77 patients that were case group (with retinopathy) 
and control group (without retinopathy). Diabetes is defined 
as fasting blood sugar equal or more than 126 mg/dl.[19] DR is 
defined as a microvascular complication of diabetes that affect 
retinal arterioles and it has two forms as nonproliferative and 
proliferative retinopathy.[20] Exclusion criteria were: Age lesser 
than 40, presence of cataract in the ophthalmologic exam that 
prevents retinopathy evaluation, noncooperative patients 
during the study. It has been explained to the participants 
that all information will be confidential and a written consent 
form were filled in by all patients. Common carotid intima-
media thickness (CIMT) is defined as the largest distance 
between the luminal intima interface and the medial adventitia 
interface that is located at 1 cm of the initiation of the common 
carotid artery[21] that was measured by one sonographist in 
recombinant position and using Doppler sonography devices 
(Siemens, G50, Germany). Demographic criteria such as age, 
duration of diabetes, body mass index (BMI), SBP and diastolic 
blood pressure (DBP), and laboratory results including fasting 
blood sugar (FBS), Glycated hemoglobin (HbA1c), blood urea 
nitrogen (BUN), and creatinine (Cr) were checked. BMI was 
measured by formula (body weight [Kg]/Length [m2]) and 
laboratory tests were conducted by Biotecnica Instruments 
(BT 3000). Collected data were entered to SPSS (Statistical 
Package for the Social Sciences, version 19.0, SPSS Inc, Chicago, 
Ill, USA) and analysis was done by t-test, Chi-square test, and 
Pearson correlation. This study was the result of research project 
number of 986, which approved by the research committee of 
Shahrekord University of Medical Sciences. Data are presented 
as mean (standard deviation).
RESULTS
Mean age of the patients was 59.65 ± 9.37 years. Mean age of 
the patients with retinopathy (Group 1) was 62.5 ± 9.75 years 
and in the patients without retinopathy (Group 2) was 
58 ± 10 years (P = 0.006). Mean CIMT of all patients was 
0.84 ± 0.18 and in the female and male patients were 
0.82 ± 0.16 mm and 0.88 ± 0.22 mm respectively (P = 0.03). In 
all of the patients, CIMT was associated with age, duration 
of diabetes (based on history), SBP, serum BUN, and Cr 
[Table 1]. The number of male and female in Group 1 was 34 
(44.2%) and 43 (55.8%) and in Group 2 were 21 (27.3%) and 
56 (72.7%), respectively. CIMT of the patients of Group 1 was 
significantly greater than Group 2 (P < 0.001). Mean HbA1c 
in Group 1 ad 2 were 7.20 ± 1.21 and7.04 ± 1.33, respectively 
(P = 0.39). Table 2 showed that in patients of Group 1, CIMT 
was correlated only with SBP (P = 0.01); however in the 
Table 1: Comparison of different variables in two groups of the patients
Variables Age (years) BMI (kg/m2) SBP (mmHg) DBP (mmHg) BUN (mg/dL) Cr (mg/dL) HbA1c (%) CIMT (mm)
Group 1 62.01±9.08 28.94±4.73 143.37±20.04 83.11±11.5 26.31±12.79 1.45±0.75 7.39±1.19 0.95±0.18
Group 2 57.29±9.84 29.63±4.07 134.94±19.03 84.35±15.6 21.13±8.79 1.1±0.36 7.01±1.29 0.73±0.11
P 0.002 0.33 0.008 0.57 0.004 <0.0001 0.39 0.0001
Group 1 = Diabetic patients with retinopathy; Group 2 = Diabetic patients without retinopathy. BMI = Body mass index; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; 
BUN = Blood urea nitrogen; Cr = Creatinine; CIMT = Carotid intima-media thickness; HbA1c = Glycosylated hemoglobin
Table 2: Association of CIMT with different variables in the patients
Variable Age BMI SBP DBP BUN Cr HbA1c FBS
Patients with retinopathy
Correlation coefficient 0.14 0.003 0.276 0.179 0.016 0.067 0.069 0.183
P 0.2 0.981 0.01 0.12 0.89 0.56 0.55 0.11
Patients without retinopathy
Correlation coefficient 0.256 0.179 0.186 0.274 0.19 0.008 0.09 0.07
P 0.2 0.11 0.11 0.03 0.09 0.94 0.42 0.51
BMI = Body mass index; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; BUN = Blood urea nitrogen; Cr = Creatinine; CIMT = Carotid intima-media thickness; 
HbA1c = Glycosylated hemoglobin; FBS = Fasting blood sugar
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patients of Group 2, CIMT was correlated with DBP. To 
remove confounding bias effect, linear regression model 
was used and the correlation between DR and CIMT was 
illustrated.
DISCUSSION
We found a significant association between CIMT and 
retinopathy in type two diabetic patients. Prevalence of DR 
in type 2 diabetic patients was reported 34.6% in Yau et al. 
study with no difference in male and female,[22] whereas 
Zhang et al. showed slightly more common in male patients.[2] 
Besides, Harris et al. found a greater prevalence and severity 
of DR in non-hispanic and Mexican Americans with type 
2 diabetes.[23] There are a few studies about correlation of 
CIMT and retinopathy in diabetic patients, for example, 
Miyamoto in evaluation of 102 diabetic patients showed the 
significant correlation between retinopathy and common 
carotid artery thickness,[24] also Torres et al. in a study on 
173 patients with hypertension showed, significant and 
independent association of carotid intima-media thickness 
with arteriolar caliber of retina.[25] In our study CIMT was 
associated with age, duration of diabetes, SBP, serum BUN, 
and Cr whereas Cardoso et al. found the correlation of CIMT 
with age, male sex, smoking status, and ambulatory blood 
pressure.[26] Ogawa et al. in a study on 634 type 2 diabetic 
patients reported the positive correlation of CIMT and 
patients BMI, also he found correlation between maximum 
BMI and retinopathy, but we didn’t find this association in 
the patients. The reason of this discrepancy may be due to 
different number of patients in two studies.[27] Correlation 
of CIMT and HTN was reported in some studies,[12,26] also 
in our study CIMT was correlated with SBP in patients with 
retinopathy and with DBP in patients without retinopathy, 
however, Alizadeh et al. in a study on 40 diabetic patients did 
not find these correlation.[28] Similar to our results, in Ogawa 
et al. study also CIMT had not correlation with control of 
blood sugar.[29] About association of HbA1c and CIMT we 
did not find a significant correlation. Furthermore similar 
result was found by Choi et al. in the study on 370 type 2 
diabetic patients.[30]
Small sample size is a limitation in our study, so we 
suggest more studies to be carried out using larger sample 
size. Therefore, the relationship between CIMT and other 
complications of diabetes such as microalbuminuria, 
macroalbuminuria or neuropathy need to be evaluated.
CONCLUSION
In diabetic patients, CIMT is a marker of atherosclerosis and 
macrovascular damage which has had a correlation with DR 
(as a potential reliable marker of microvascular damage), so 
we may use sonographic measurement of CIMT as a simple, 
available, and noninvasive method for screening of macro 
and microvascular complications among diabetic patients.
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